Phenominer Database Results (28 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Experiment Notes Record ID Study ID
GK/MolTac body weight control condition Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. body mass male 147 days 0 389.0 g 7.0 body weighing method 0.0 0 103983 2885
GK/MolTac body weight running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours) Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. body mass male 147 days 0 374.0 g 4.0 body weighing method 0.0 0 103984 2885
GK/MolTac body weight control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. body mass male 147 days 0 389.0 g 7.0 body weighing method 0.0 0 103985 2885
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 105 days 9 337.3 g 7.8 23.4 body weighing method 0.0 0 110731 3183
GK/MolTac body weight control condition Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. body mass female 56 days 10 191.0 g 3.0 9.49 body weighing method 0.0 0 110244 3168
GK/MolTac body weight control condition Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. body mass male 147 days 6 382.0 g 13.0 31.84 body weighing method 0.0 0 103981 2885
GK/MolTac body weight control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. body mass female 240 days 11 280.0 g 6.0 19.9 body weighing method 0.0 0 body weight 106894 3071
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 112 days 10 352.4 g 6.5 20.55 body weighing method 0.0 0 110733 3183
GK/MolTac body weight control IgG monoclonal antibody (1 mg) (for 14 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. body mass female 70 days 9 207.0 g 5.0 15.0 body weighing method 0.0 0 110247 3168
GK/MolTac body weight anti-rh-VEGF165 monoclonal antibody (1 mg) (for 14 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. body mass female 70 days 10 212.0 g 5.0 15.81 body weighing method 0.0 0 110248 3168
GK/MolTac body weight anti-rh-VEGF165 monoclonal antibody (1 mg) (for 28 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. body mass female 84 days 10 235.0 g 5.0 15.81 body weighing method 0.0 0 110252 3168
GK/MolTac body weight running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours) Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. body mass male 147 days 6 373.0 g 5.0 12.25 body weighing method 0.0 0 103982 2885
GK/MolTac body weight running on treadmill (0-10 m/min) (between 0.1 and 0.2 hours) then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) then running on treadmill (15 m/min) (for 0.5 hours) then running on treadmill (15 m/min) (for 0.8 hours) Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. body mass male 147 days 0 366.0 g 6.0 body weighing method 0.0 0 103986 2885
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 105 days 8 325.4 g 9.2 26.02 body weighing method 0.0 0 110729 3183
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 112 days 8 337.1 g 9.3 26.3 body weighing method 0.0 0 110732 3183
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 119 days 8 343.0 g 9.0 25.46 body weighing method 0.0 0 110735 3183
GK/MolTac body weight control condition Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. body mass female 56 days 9 188.0 g 3.0 9.0 body weighing method 0.0 0 110243 3168
GK/MolTac body weight control condition Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. body mass male 112 days 0 351.0 g 5.0 body weighing method 0.0 0 108025 3109
GK/MolTac body weight control condition Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. body mass male 154 days 0 419.0 g 7.0 body weighing method 0.0 0 108027 3109
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 112 days 9 345.8 g 8.4 25.2 body weighing method 0.0 0 110734 3183
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 119 days 10 350.1 g 7.7 24.35 body weighing method 0.0 0 110736 3183
GK/MolTac body weight control IgG monoclonal antibody (1 mg) (for 42 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. body mass female 98 days 9 237.0 g 4.0 12.0 body weighing method 0.0 0 110255 3168
GK/MolTac body weight control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. body mass female 60 days 6 209.0 g 6.0 14.7 body weighing method 0.0 0 body weight 106893 3071
GK/MolTac body weight control condition Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. body mass female 420 days 11 292.0 g 6.0 19.9 body weighing method 0.0 0 body weight 106895 3071
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 105 days 10 335.6 g 5.2 16.44 body weighing method 0.0 0 110730 3183
GK/MolTac body weight control condition Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. body mass male 119 days 9 350.8 g 9.8 29.4 body weighing method 0.0 0 110737 3183
GK/MolTac body weight control IgG monoclonal antibody (1 mg) (for 28 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. body mass female 84 days 9 230.0 g 4.0 12.0 body weighing method 0.0 0 110251 3168
GK/MolTac body weight anti-rh-VEGF165 monoclonal antibody (1 mg) (for 42 days) Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. body mass female 98 days 10 241.0 g 5.0 15.81 body weighing method 0.0 0 110256 3168